skip to Main Content

Passionate about Science

World-class drug discovery expertise
and an unprecedented track record with 4 drugs on the market

Passionate about Science

World-class drug discovery expertise
and an unprecedented track record with 4 drugs on the market

WHYUS

We offer a unique blend of broad scientific expertise, global pharma heritage, and unprecedented success in bringing drug discovery projects from conception to the clinic. With a passionate, interdisciplinary and accomplished team, and capabilities ranging from target validation to clinical candidate nomination, we bring great science to your project.

NewsEvents

IRBM Biomarkers Series UK

Manuel Daldin, Scientist - High Throughput Biology and Screening and Heidi Kingdon Jones, Global VP Business Development are attending the…

read more

The Jenner Institute signs an agreement with Advent to develop a novel coronavirus vaccine

The Jenner Institute, Oxford University, UK and Advent Srl – an IRBM company, Pomezia,Italy - are continuing their long-standing history…

Piero Di Lorenzo presents the High Science TV project to Premier Conte

Annual JP Morgan Healthcare Conference

Next week, IRBM’s Vice Presidents, Dan Conlon and Michele Luche will be attending the annual JP Morgan Healthcare Conference –…

IRBMPHOTOS

IRBMVIDEOS

Back To Top